STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

IFF Pharma Solutions Wins Pharmaceutical Technology Excellence Award

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags

IFF Pharma Solutions has been awarded the 2024 Pharmaceutical Technology Excellence Award in the Brand Leadership category for its 'Timing is Everything' campaign. The campaign showcases IFF's new controlled release platform for oral drug delivery, implementing a three-pronged approach including social media teasers, video content, and a microsite.

The platform features key products including METHOCEL™, ETHOCEL™, and POLYOX™, focusing on controlled release polymers in pharmaceutical formulations. The campaign creates a comprehensive thought leadership platform providing educational resources such as white papers, webinars, and articles about controlled release of active ingredients.

The Pharmaceutical Technology Excellence Awards, powered by GlobalData's business intelligence, recognizes significant achievements and innovations in the pharmaceutical industry. The award acknowledges the campaign's strategic marketing tactics, creativity, and leadership in building an integrated thought leadership platform.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.44% News Effect

On the day this news was published, IFF gained 0.44%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Recognized for brand leadership with its "Timing is Everything" controlled release platform for oral drug delivery.

NEW YORK, Jan. 14, 2025 /PRNewswire/ -- IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, announced today that it has won the 2024 Pharmaceutical Technology Excellence Awards' Brand Leadership category for its "Timing is Everything" campaign. The campaign features IFF's newly designed controlled release platform, which provides customers with solutions at every turn.

This award recognizes "Timing is Everything" campaign for its strategic marketing tactics, creativity and leadership. The campaign focuses on building an integrated thought leadership platform for controlled release through storylines and cohesive branding. It includes a three-pronged approach with a social media teaser countdown, video and microsite.

"We are honored to receive this esteemed recognition for our 'Timing is Everything' campaign that highlights our controlled release portfolio," said Lisa M. Miree-Luke, global communications director, IFF Pharma Solutions. "This award is a testament to our trailblazing products and the passionate teams behind them. METHOCEL™─Pioneering Then, Innovating Now; ETHOCEL™─Proven Time After Time and POLYOX™─Versatile Across Complex and Unique Applications, they are not just taglines but promises we stand by. We are committed to driving innovation, quality and helping to enable our customers' successes."

The "Timing is Everything" campaign elevates brand awareness and culminates in the creation of a best-in-class dedicated thought leadership platform for controlled release polymers in the excipients industry. The platform educates visitors about pharmaceutical formulations that benefit patients and the importance of controlled release of active ingredients through comprehensive materials such as white papers, webinars and articles.

The Pharmaceutical Technology Excellence Awards honors the most significant achievements and innovations in the pharmaceutical industry. Powered by GlobalData's business intelligence, the awards recognize the people and companies leading change and shaping the future of the industry.

###

Welcome to IFF

At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.comLinkedInInstagram and Facebook.

©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with TM, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

Contact:
Emily Kaufman
Global Communications Specialist
+1 9086705691
Emily.Kaufman@iff.com

SOURCE IFF

FAQ

What award did IFF Pharma Solutions win in 2024?

IFF Pharma Solutions won the 2024 Pharmaceutical Technology Excellence Award in the Brand Leadership category for its 'Timing is Everything' campaign.

What are the key products featured in IFF's controlled release platform?

The platform features METHOCEL™, ETHOCEL™, and POLYOX™ products for controlled release applications in pharmaceutical formulations.

What components are included in IFF's 'Timing is Everything' campaign?

The campaign includes a three-pronged approach with a social media teaser countdown, video content, and a dedicated microsite.

How does IFF's controlled release platform benefit the pharmaceutical industry?

The platform provides educational resources about pharmaceutical formulations that benefit patients through controlled release of active ingredients, offering comprehensive materials like white papers, webinars, and articles.

What is the purpose of IFF's 'Timing is Everything' campaign?

The campaign aims to elevate brand awareness and create a best-in-class thought leadership platform for controlled release polymers in the excipients industry.
International Flavors&Fragranc

NYSE:IFF

IFF Rankings

IFF Latest News

IFF Latest SEC Filings

IFF Stock Data

16.20B
250.99M
0.1%
97.25%
1.8%
Specialty Chemicals
Industrial Organic Chemicals
Link
United States
NEW YORK